cyclin I Activators
Cyclin I activators encompass a variety of chemical compounds that, through diverse mechanisms, indirectly augment the functional activity of cyclin I. Forskolin and Isoprenaline, for instance, elevate intracellular cAMP levels, which activate protein kinase A (PKA). PKA can phosphorylate several substrates and transcription factors that may interact with cyclin I, thereby enhancing cyclin I's role in controlling gene expression pertinent to the cell cycle. Similarly, by stabilizing microtubules, Paclitaxel indirectly promotes cyclin I activity during the G2/M phase, which is crucial for proper cell cycle progression. Retinoic Acid and Sulforaphane modulate transcriptional activity by influencing gene expression patterns that involve cyclin I, thus indirectly enhancing its regulatory functions. Lithium Chloride's inhibition of GSK-3 stabilizes transcription factors that may augment cyclin I's activity, while Trichostatin A and Sodium Butyrate, as histone deacetylase inhibitors, can potentially increase the transcription of genes regulated by cyclin I through modification of the chromatin structure.
On the other hand, compounds like Roscovitine and Olomoucine selectively inhibit CDKs that compete with cyclin I, thereby potentially increasing the pool of CDKs available to form active complexes with cyclin I, which is essential for its functional activity in cell cycle transitions and transcriptional regulation. The inhibition of DNA methyltransferase by 5-Azacytidine may also indirectly enhance cyclin I activity by increasing the expression of proteins that interact with cyclin I, influencing cell cycle checkpoints. Moreover, Rapamycin's inhibition of mTOR signaling can indirectly support cyclin I's involvement in cell growth and proliferation by modulating the synthesis of proteins relevant to cyclin I's function. Collectively, these chemical activators facilitate the enhancement of cyclin I-mediated functions, crucial to cell cycle progression and gene expression, without necessitating the upregulation of its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol Hydrochloride is a synthetic non-selective beta-adrenergic agonist. It increases cAMP levels, which can lead to the activation of PKA. PKA can phosphorylate substrates that may indirectly enhance cyclin I activity by modulating the cell cycle and affecting transcriptional regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene that activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which could phosphorylate transcription factors and co-factors interacting with cyclin I, indirectly enhancing its role in gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, modulates cell growth and differentiation. It influences transcription factors that can interact with cyclin I, potentially increasing its participation in the regulation of gene expression linked to the cell cycle and development. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, a kinase involved in numerous signaling pathways. Inhibition of GSK-3 could stabilize transcription factors that may associate with cyclin I, enhancing its activity in cell cycle control and transcription regulation. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules and can arrest cells in the G2/M phase of the cell cycle. This stabilization might enhance cyclin I activity by prolonging its association with CDKs during cell cycle checkpoints, thus indirectly influencing its functional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By altering chromatin structure and gene expression, it could enhance the activity of cyclin I by facilitating the transcription of genes that cyclin I-CDK complexes regulate. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the signaling pathway involved in cell growth and proliferation. Through the inhibition of mTOR, rapamycin could indirectly enhance cyclin I's role in cell cycle progression by modulating the synthesis of proteins that interact with cyclin I. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a nucleoside analog that inhibits DNA methyltransferase, leading to hypomethylation of DNA and affecting gene expression. It could enhance cyclin I activity by increasing the expression of genes that encode proteins interacting with cyclin I, thereby influencing its role in cell cycle regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor. It could enhance the activity of cyclin I by promoting acetylation of histones near genes regulated by cyclin I, potentially increasing its transcriptional activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane is an isothiocyanate from cruciferous vegetables that has been shown to affect gene expression. It may enhance cyclin I activity by modulating transcription factor activity and chromatin structure, indirectly influencing cyclin I's involvement in gene expression. | ||||||